Difference between revisions of "Team:San Andres/Software"
Line 359: | Line 359: | ||
.gwd-img-z62c { | .gwd-img-z62c { | ||
position: absolute; | position: absolute; | ||
− | left: | + | left: 101.97689107253px; |
− | top: | + | top: 727.996188652538px; |
} | } | ||
.gwd-p-twn1 { | .gwd-p-twn1 { | ||
Line 372: | Line 372: | ||
} | } | ||
.gwd-p-8ky1 { | .gwd-p-8ky1 { | ||
+ | text-align: justify; | ||
+ | } | ||
+ | .gwd-span-1jyf { | ||
+ | font-family: sans-serif; | ||
+ | font-size: 12.7px; | ||
+ | line-height: 19.05px; | ||
+ | background-color: rgb(255, 255, 255); | ||
+ | } | ||
+ | .gwd-div-ryc2 { | ||
+ | position: absolute; | ||
+ | width: 10.1449275362px; | ||
+ | height: 33.3333333333px; | ||
+ | left: 194px; | ||
+ | top: 678px; | ||
+ | text-align: left; | ||
+ | color: rgb(0, 0, 0); | ||
+ | } | ||
+ | .gwd-p-zq3p { | ||
+ | text-align: justify; | ||
+ | } | ||
+ | .gwd-p-pao5 { | ||
+ | text-align: justify; | ||
+ | } | ||
+ | .gwd-div-bvfc { | ||
+ | position: absolute; | ||
+ | left: 1151px; | ||
+ | top: 546px; | ||
+ | text-align: left; | ||
+ | color: rgb(0, 0, 0); | ||
+ | } | ||
+ | .gwd-p-8hyq { | ||
+ | text-align: justify; | ||
+ | } | ||
+ | .gwd-p-4por { | ||
text-align: justify; | text-align: justify; | ||
} | } | ||
Line 405: | Line 439: | ||
</div> | </div> | ||
<div class="gwd-div-cr20"> | <div class="gwd-div-cr20"> | ||
− | <h1 class="gwd-h1-wm1x editable"><span class="gwd-span-5p9l">Abstract</span></h1> | + | <h1 class="gwd-h1-wm1x editable"><span class="gwd-span-5p9l"><strong>Abstract</strong></span></h1> |
<div> | <div> | ||
<div class="gwd-div-245r"> | <div class="gwd-div-245r"> | ||
− | <p | + | <p><big>The celiac disease affects 1 in 265 people worldwide and 15% of |
− | + | population in Chile. This in an irreversible autoimmune disease in | |
+ | which due to the presence of genes HLA DQ2 or HLA DQ8 in those | ||
+ | affected, the consumption of foods containing gluten (all fods derived | ||
+ | from wheat, barley, rye, etc.) cause an inflammation in small intestine | ||
+ | causing multiple effects in the organism (diarrhea, constipation, porr | ||
+ | absorption, among others) significantly affecting their quatily of life.</big><span class="gwd-span-1jyf"> </span> | ||
+ | </p> | ||
+ | <p><big>Whereas | ||
+ | the majority of the world food contains gluten, we propose a treatment | ||
+ | for those who can't eat gluten, and can do so without problems. In | ||
+ | detail, our project involves a system able to degrade gluten via the | ||
+ | enzyme KumaMax and report the operation simultaneously with a red | ||
+ | fluorescent protein. The foregoing, works in a genetically modified E. | ||
+ | coli bacteria. With this project, in long run, we hope to improve the | ||
+ | quality of life of all those reported with celiac disease. People who | ||
+ | suffer from gluten intolerance have an adverse reaction to gluten | ||
+ | proteins found in wheat, barley, and rye products.</big> | ||
</p> | </p> | ||
− | |||
− | |||
− | |||
</div><span lang="EN-US" class="gwd-span-03v9"> | </div><span lang="EN-US" class="gwd-span-03v9"> | ||
<!--[if !supportLineBreakNewLine]--><br> | <!--[if !supportLineBreakNewLine]--><br> | ||
Line 424: | Line 471: | ||
</div> | </div> | ||
<img src="https://static.igem.org/mediawiki/2015/thumb/9/93/Ex_2.jpg/800px-Ex_2.jpg" class="gwd-img-z62c"> | <img src="https://static.igem.org/mediawiki/2015/thumb/9/93/Ex_2.jpg/800px-Ex_2.jpg" class="gwd-img-z62c"> | ||
+ | <div class="gwd-div-ryc2"></div> | ||
+ | <div class="gwd-div-bvfc"></div> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 00:34, 13 August 2015
Abstract
The celiac disease affects 1 in 265 people worldwide and 15% of population in Chile. This in an irreversible autoimmune disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those affected, the consumption of foods containing gluten (all fods derived from wheat, barley, rye, etc.) cause an inflammation in small intestine causing multiple effects in the organism (diarrhea, constipation, porr absorption, among others) significantly affecting their quatily of life.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.